HOME >> MEDICINE >> NEWS
Surprising results for Ugandan HIV intervention trial

Results of a study in this week's issue of THE LANCET show how interventions to promote safer sex and the control of sexually transmitted diseases did not reduce the incidence of HIV infection in an area of rural Uganda.

Treatment of sexually transmitted infections (STIs) and behavioural interventions are the main methods to prevent HIV in developing countries. Anatoli Kamali from the Medical Research Council Programme on AIDS in Uganda and colleagues assessed the effect of behaviour change and STI management on the incidence of HIV-1 and other STIs in Uganda.

All adults living in 18 communities in rural Uganda were randomly allocated into three groups: the first group received behavioural interventions alone (promotion of safer sex behaviour); the second group received both behavioural and STI interventions; the third was a control group where individuals received routine government health services and community development activities.

Follow-up took place after three and a half to four years. Only condom use with last casual partner increased significantly more in the two intervention groups compared with the control group. Despite significant reductions in acute syphilis, gonorrhoea, and unprotected casual sex in the combined intervention group, there was no effect on HIV incidence attributable to either intervention. The investigators comment that more effective STI and behavioural interventions need to be developed for HIV control in mature epidemics in countries like Uganda.

Judith Stephenson and Frances Cowan from the Royal Free and University College Medical School, London, UK, observe in an accompanying Commentary (p 633) that the timing of the study could partly explain the surprising results; the fact that the overall HIV incidence is falling in Uganda suggests that the study could have been underpowered to detect substantial differences in HIV incidence between the intervention and control groups. They conclude: "What does this tria
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
20-Feb-2003


Page: 1 2

Related medicine news :

1. Surprising findings on Medicaid kids and the ER
2. New studies show mixed results on epilepsy drugs and birth defects
3. Study of obese diabetics explains why low-carb diets produce fast results
4. Sharing clinical trial results with participants may be beneficial
5. Emergency clopidogrel could save thousands of lives46,000-patient heart attack trial results
6. Similar results found in both older and younger patients undergoing weight-loss surgery
7. OHSU researcher says FDA could broaden access to results of clinical drug trials
8. Kinder, gentler procedure gives superior results for stem cell transplants
9. Good results with only one egg in in-vitro fertilization
10. Holiday feasting could sabotage liposuction results
11. Early results shed light on lung cancer screening advance

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Surprising results for Ugandan HIV intervention trial

(Date:7/31/2015)... ... July 31, 2015 , ... M3 USA MDLinx.com, source of the Smartest Doc ... Exam Courses. , The additions of Gastroenterology, Pulmonology and Allergy/Immunology round out an ... preparing for the exam easy and painless. MDLinx offers thousands of board-exam style ...
(Date:7/31/2015)... CA (PRWEB) , ... July 31, 2015 , ... According to the article ... floor of the Pasadena courthouse was contained and extinguished by the city’s fire department before ... in the building at the time of the fire, and it was a fire alarm ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Well-known for its ... offering wedding cakes with custom designs, making life just a little bit ... designed wedding cakes for each customer who orders one. , The bakery provides a ...
(Date:7/31/2015)... ... , ... Cosmetic Town has proven itself as the leader ... procedures including, but not limited to, abdominoplasty, blepharoplasty, rhinoplasty and septoplasty. The ... , Staying up to date with the latest cosmetic trends has never ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... a one-day event geared to patients and family members, medical professionals, and researchers, ... regional mesothelioma experts. The conference is a collaborative effort between the Mesothelioma Applied ...
Breaking Medicine News(10 mins):Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 2Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 3Health News:Pastry Palace of Las Vegas Announces It Is Now Offering Custom Wedding Cakes in Las Vegas 2Health News:Cosmetic Town: Now Providing Interactive And Vital Medical Knowledge 2Health News:New York Area Mesothelioma Specialists to Present at Conference 2Health News:New York Area Mesothelioma Specialists to Present at Conference 3
(Date:7/31/2015)... SAN DIEGO , July 31, 2015  Eisai ... Ltd. (Headquarters: Tokyo , President and ... Inc. (Headquarters: San Diego, California , ... HALO") have signed a clinical collaboration agreement to evaluate ... in combination with Halozyme,s investigational drug PEGPH20 (PEGylated recombinant ...
(Date:7/30/2015)... July 30, 2015 Edwards Lifesciences Corporation (NYSE: ... valves and hemodynamic monitoring, today announced that Robert A. ... "Bob is an ardent champion for innovation in ... to have him on Edwards, board as we pursue our ... chairman and CEO.  "Bob has provided a valuable perspective to ...
(Date:7/30/2015)... 2015  ResMed Inc. (NYSE: RMD ) today ...  Revenue for the quarter was $453.1 million, a 9 ... 2014 (a 17 percent increase on a constant currency ... quarter ended June 30, 2014.  Diluted earnings per share ... ended June 30, 2014.  The results ...
Breaking Medicine Technology:Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16
Cached News: